A New Classification of Prodrugs: Regulatory Perspectives

Author： Wu Kuei-Meng  

Publisher： MDPI

E-ISSN： 1424-8247|2|3|77-81

ISSN： 1424-8247

Source： Pharmaceuticals, Vol.2, Iss.3, 2009-10, pp. : 77-81

Access to resources Favorite

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Scientific and Regulatory Perspectives in Herbal and Dietary Supplement Associated Hepatotoxicity in the United States

By Avigan Mark I.   Mozersky Robert P.   Seeff Leonard B.  

International Journal of Molecular Sciences, Vol. 17, Iss. 3, 2016-03 ,pp. : 331-331

MDPI

Access to resources Recommend Favorite

The Medicinal Chemistry of Imidazotetrazine Prodrugs

By Moody Catherine L.   Wheelhouse Richard T  

Pharmaceuticals, Vol. 7, Iss. 7, 2014-07 ,pp. : 797-838

MDPI

Access to resources Recommend Favorite

Transcriptome Profiling in Human Diseases: New Advances and Perspectives

By Casamassimi Amelia   Federico Antonio   Rienzo Monica   Esposito Sabrina   Ciccodicola Alfredo  

International Journal of Molecular Sciences, Vol. 18, Iss. 8, 2017-07 ,pp. : 1652-1652

MDPI

Access to resources Recommend Favorite

miRNA as a New Regulatory Mechanism of Estrogen Vascular Action

By Pérez-Cremades Daniel   Mompeón Ana   Vidal-Gómez Xavier   Hermenegildo Carlos   Novella Susana  

International Journal of Molecular Sciences, Vol. 19, Iss. 2, 2018-02 ,pp. : 473-473

MDPI

Access to resources Recommend Favorite

Glutathione Transferase (GST)-Activated Prodrugs

By Ruzza Paolo   Calderan Andrea  

Pharmaceutics, Vol. 5, Iss. 2, 2013-04 ,pp. : 220-231

MDPI

Access to resources Recommend Favorite